Medically reviewed by Qin Rao, MD Pancolitis, or extensive colitis, is a form of ulcerative colitis (UC) in which ...

There are two conditions related to ulcerative colitis, erythema nodosum and pyoderma gangrenosum. Erythema nodosum consists of painful red bumps under the skin that may develop when the ulcerative ...

Ulcerative colitis is a type of chronic inflammatory bowel disease that causes painful ulcers and irritation in the large intestine. In North America alone, it is estimated to affect more than ...

Ulcerative colitis is a relatively common long-term condition that causes inflammation in the colon. Dietary changes and medications can often help manage symptoms, but surgery is an option in ...

For the 907,000 Americans with ulcerative colitis, living with symptoms like urgent bowel movements, abdominal cramps, and loose or bloody stools can be overwhelming, but treatments can help keep ...

MK-6194 is under clinical development by Merck and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase II drugs for Ulcerative Colitis have a 45% phase transition success rate ...

If your ulcerative colitis (UC) hasn’t responded well enough ... to select a pouch that fits your stoma size, activity level, skin condition, and budget. Here are some pros and cons of ...

Ulcerative colitis usually causes diarrhea, which may be watery and appear fluffy, mushy, or bloody. You may also experience constipation, which may present as small, hard stool lumps. Ulcerative ...

Clostridioides difficile (C. diff) is a bacterial infection that commonly affects people with ulcerative colitis (UC). It can worsen symptoms and cause complications. It can also trigger a ...

Every year, more and more Americans are being diagnosed with inflammatory bowel disease. Who’s at risk for IBD, and what are the warning signs?

For people living with ulcerative colitis (UC), a chronic inflammatory bowel disease that causes inflammation and affects the lining of the colon and rectum, it can be similarly difficult to ...

Teva stock catapulted Tuesday after its inflammatory bowel disease treatment showed "best-in-class potential" in a Phase 2 ...